These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1133736)

  • 1. Central versus peripheral anticholinergic activity as assessed by two in vivo procedures in mice.
    Malick JB; Barnett A
    J Pharm Sci; 1975 Jun; 64(6):1066-8. PubMed ID: 1133736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticholinergic drugs, blood-brain-barrier and tonic immobility in chickens.
    Hughes RA
    Physiol Behav; 1982 Jul; 29(1):67-71. PubMed ID: 7122737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant actions of anticholinergic drugs in soman poisoning.
    Capacio BR; Shih TM
    Epilepsia; 1991; 32(5):604-15. PubMed ID: 1915166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic effects of scopolamine and atropine on the physostigmine response in man.
    Janowsky D; Risch SC; Ziegler M; Gillin JC
    Mil Med; 1987 Nov; 152(11):579-81. PubMed ID: 3122083
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of physostigmine, atropine and scopolamine on behavior maintained by a multiple schedule of food presentation in the mouse.
    Wenger GR
    J Pharmacol Exp Ther; 1979 Apr; 209(1):137-43. PubMed ID: 430373
    [No Abstract]   [Full Text] [Related]  

  • 6. Time-related facilitation and suppression of drinking by muscarinic anticholinergic drugs in water non-deprived rats.
    Kuribara H; Tadokoro S
    Jpn J Pharmacol; 1988 Oct; 48(2):195-201. PubMed ID: 3210445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anticholinergic effects depending on the chemical constitution of a series of tertiary and quaternary propylamine derivatives].
    Ehrhart G; Härtfelder G; Schmitt K
    Arzneimittelforschung; 1970 Aug; 20(8):1094-6. PubMed ID: 5536510
    [No Abstract]   [Full Text] [Related]  

  • 8. Relationship of the behavioral effects of aprophen, atropine and scopolamine to antagonism of the behavioral effects of physostigmine.
    Genovese RF; Elsmore TF; Witkin JM
    Pharmacol Biochem Behav; 1990 Sep; 37(1):117-22. PubMed ID: 2263653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of physostigmine-induced lethality in rats. A pharmacological analysis.
    Niemegeers CJ; Awouters F; Lenaerts FM; Vermeire J; Janssen PA
    Arch Int Pharmacodyn Ther; 1982 Sep; 259(1):153-65. PubMed ID: 6129832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticholinergic properties of oxitropium bromide (Ba 253) and its metabolites].
    Kitagawa H; Takeda F; Izumita M; Hayashi T; Kohei H
    Nihon Yakurigaku Zasshi; 1989 Feb; 93(2):49-54. PubMed ID: 2524433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centrally active antimuscarinic analogs of oxotremorine selectively block physostigmine-induced hypertension, but not peripheral muscarinic vasodepression.
    Vargas HM; Ringdahl B
    J Pharmacol Exp Ther; 1990 Apr; 253(1):165-70. PubMed ID: 2329503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On differences in the penetration of the hemato-encephalic barrier by cholinolytic agents].
    Pechenkin VA
    Biull Eksp Biol Med; 1966 May; 61(5):72-4. PubMed ID: 6002397
    [No Abstract]   [Full Text] [Related]  

  • 13. Central and peripheral actions of anticholinergic drugs when administered with triflupromazine.
    Brimblecombe RW; Green DM; Aldous FA; Thompson PB
    Neuropharmacology; 1971 Jan; 10(1):93-101. PubMed ID: 5569310
    [No Abstract]   [Full Text] [Related]  

  • 14. Soft drugs--XIV. Synthesis and anticholinergic activity of soft phenylsuccinic analogs of methatropine.
    Hammer RH; Gunes E; Kumar GN; Wu WM; Srinivasan V; Bodor NS
    Bioorg Med Chem; 1993 Sep; 1(3):183-7. PubMed ID: 8081850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-muscarinic drug effects in a swim-to-platform test: dose-response relations.
    Vanderwolf CH
    Behav Brain Res; 1991 Aug; 44(2):217-9. PubMed ID: 1751013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of physostigmine induced lethality by a combination of scopolamine and methscopolamine.
    Janowsky DS; Berkowitz A; Turken A; Risch SC
    Acta Pharmacol Toxicol (Copenh); 1985 Feb; 56(2):154-7. PubMed ID: 3993383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of the anticholinergic bronchospasmolytic agent flutropium bromide.
    Bauer R; Fügner A
    Arzneimittelforschung; 1986 Sep; 36(9):1348-52. PubMed ID: 2431695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaco-ethological analysis of agonistic behavior between resident and intruder mice: effect of anticholinergic drugs.
    Yoshimura H; Ogawa N
    Jpn J Pharmacol; 1982 Dec; 32(6):1111-6. PubMed ID: 6891725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of anticholinergic bronchodilators on mucociliary transport and airway secretion.
    Miyata T; Matsumoto N; Yuki H; Oda Y; Takahama K; Kai H
    Jpn J Pharmacol; 1989 Sep; 51(1):11-5. PubMed ID: 2530378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mydriatic effect of anticholinergic drugs used during reversal of nondepolarizing muscle relaxants.
    Schwartz H; Apt L
    Am J Ophthalmol; 1979 Sep; 88(3 Pt 2):609-12. PubMed ID: 484693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.